Literature DB >> 25214894

Understanding susceptibility to breast cancer metastasis: the genetic approach.

Anjali Shukla1, Jude Alsarraj1, Kent Hunter1.   

Abstract

Metastasis is a complex phenotype that is not discrete, is polygenic, varies in range over the entire population and follows non-Mendelian inheritance. Recent evidence indicates that inherited susceptibility affects not only the development of the primary tumor, but is also an important factor in progression and metastasis. Since metastasis accounts for the majority of breast cancer deaths, identification and understanding of the genetic modifiers of metastasis underlies success of personalized therapy. Studies from our laboratory and others have now characterized several metastasis susceptibility factors. While an important step forward, these certainly do not describe the entire metastatic phenomenon and efforts continue to expand this knowledge. Here we review the complex metastatic process and current knowledge on the genetics of breast cancer metastasis, including germline polymorphisms that have been associated with the disease.

Entities:  

Year:  2014        PMID: 25214894      PMCID: PMC4157690          DOI: 10.2217/bmt.14.1

Source DB:  PubMed          Journal:  Breast Cancer Manag        ISSN: 1758-1923


  41 in total

1.  Deletion of the proline-rich region of the murine metastasis susceptibility gene Brd4 promotes epithelial-to-mesenchymal transition- and stem cell-like conversion.

Authors:  Jude Alsarraj; Renard C Walker; Joshua D Webster; Thomas R Geiger; Nigel P S Crawford; R Mark Simpson; Keiko Ozato; Kent W Hunter
Journal:  Cancer Res       Date:  2011-03-09       Impact factor: 12.701

Review 2.  Mouse models of cancer: does the strain matter?

Authors:  Kent W Hunter
Journal:  Nat Rev Cancer       Date:  2012-01-19       Impact factor: 60.716

3.  Bromodomain protein Brd4 binds to GTPase-activating SPA-1, modulating its activity and subcellular localization.

Authors:  Andrea Farina; Masakazu Hattori; Jun Qin; Yoshihiro Nakatani; Nagahiro Minato; Keiko Ozato
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

4.  Bromodomain 4 activation predicts breast cancer survival.

Authors:  Nigel P S Crawford; Jude Alsarraj; Luanne Lukes; Renard C Walker; Jennifer S Officewala; Howard H Yang; Maxwell P Lee; Keiko Ozato; Kent W Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-21       Impact factor: 11.205

5.  Genes that mediate breast cancer metastasis to the brain.

Authors:  Paula D Bos; Xiang H-F Zhang; Cristina Nadal; Weiping Shu; Roger R Gomis; Don X Nguyen; Andy J Minn; Marc J van de Vijver; William L Gerald; John A Foekens; Joan Massagué
Journal:  Nature       Date:  2009-05-06       Impact factor: 49.962

Review 6.  Genetic determinants of cancer metastasis.

Authors:  Don X Nguyen; Joan Massagué
Journal:  Nat Rev Genet       Date:  2007-05       Impact factor: 53.242

7.  Lung metastasis genes couple breast tumor size and metastatic spread.

Authors:  Andy J Minn; Gaorav P Gupta; David Padua; Paula Bos; Don X Nguyen; Dimitry Nuyten; Bas Kreike; Yi Zhang; Yixin Wang; Hemant Ishwaran; John A Foekens; Marc van de Vijver; Joan Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-09       Impact factor: 11.205

Review 8.  Genetic susceptibility to breast cancer.

Authors:  Angela R Bradbury; Olufunmilayo I Olopade
Journal:  Rev Endocr Metab Disord       Date:  2007-05-17       Impact factor: 6.514

9.  Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression.

Authors:  T Lifsted; T Le Voyer; M Williams; W Muller; A Klein-Szanto; K H Buetow; K W Hunter
Journal:  Int J Cancer       Date:  1998-08-12       Impact factor: 7.396

10.  Transcriptome and genome sequencing uncovers functional variation in humans.

Authors:  Tuuli Lappalainen; Michael Sammeth; Marc R Friedländer; Peter A C 't Hoen; Jean Monlong; Manuel A Rivas; Mar Gonzàlez-Porta; Natalja Kurbatova; Thasso Griebel; Pedro G Ferreira; Matthias Barann; Thomas Wieland; Liliana Greger; Maarten van Iterson; Jonas Almlöf; Paolo Ribeca; Irina Pulyakhina; Daniela Esser; Thomas Giger; Andrew Tikhonov; Marc Sultan; Gabrielle Bertier; Daniel G MacArthur; Monkol Lek; Esther Lizano; Henk P J Buermans; Ismael Padioleau; Thomas Schwarzmayr; Olof Karlberg; Halit Ongen; Helena Kilpinen; Sergi Beltran; Marta Gut; Katja Kahlem; Vyacheslav Amstislavskiy; Oliver Stegle; Matti Pirinen; Stephen B Montgomery; Peter Donnelly; Mark I McCarthy; Paul Flicek; Tim M Strom; Hans Lehrach; Stefan Schreiber; Ralf Sudbrak; Angel Carracedo; Stylianos E Antonarakis; Robert Häsler; Ann-Christine Syvänen; Gert-Jan van Ommen; Alvis Brazma; Thomas Meitinger; Philip Rosenstiel; Roderic Guigó; Ivo G Gut; Xavier Estivill; Emmanouil T Dermitzakis
Journal:  Nature       Date:  2013-09-15       Impact factor: 49.962

View more
  4 in total

1.  Overexpressed in colorectal carcinoma gene (OCC-1) upregulation and APPL2 gene downregulation in breast cancer specimens.

Authors:  Abolfazl Ghalaei; Maryam Kay; Shiva Zarrinfam; Parisa Hoseinpour; Mehrdad Behmanesh; Bahram M Soltani
Journal:  Mol Biol Rep       Date:  2018-09-14       Impact factor: 2.316

Review 2.  Metastasis as a systemic disease: molecular insights and clinical implications.

Authors:  Maša Alečković; Sandra S McAllister; Kornelia Polyak
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-06-14       Impact factor: 10.680

3.  SNP mutation-related genes in breast cancer for monitoring and prognosis of patients: A study based on the TCGA database.

Authors:  Chundi Gao; Jing Zhuang; Chao Zhou; Huayao Li; Cun Liu; Lijuan Liu; Fubin Feng; Ruijuan Liu; Changgang Sun
Journal:  Cancer Med       Date:  2019-03-18       Impact factor: 4.711

Review 4.  MicroRNA-361: A Multifaceted Player Regulating Tumor Aggressiveness and Tumor Microenvironment Formation.

Authors:  Daozhi Xu; Peixin Dong; Ying Xiong; Junming Yue; Kei Ihira; Yosuke Konno; Noriko Kobayashi; Yukiharu Todo; Hidemichi Watari
Journal:  Cancers (Basel)       Date:  2019-08-07       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.